U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.95
    +0.52 (+0.48%)
     
  • Gold

    1,813.50
    +12.00 (+0.67%)
     
  • Silver

    19.81
    +0.14 (+0.70%)
     
  • EUR/USD

    1.0435
    +0.0009 (+0.08%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • GBP/USD

    1.2101
    -0.0002 (-0.02%)
     
  • USD/JPY

    135.4500
    +0.2750 (+0.20%)
     
  • BTC-USD

    19,135.50
    +75.10 (+0.39%)
     
  • CMC Crypto 200

    413.27
    -6.87 (-1.64%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    26,152.26
    +216.64 (+0.84%)
     

World Microneedle Measurable Chronic Disease Biomarkers Industry 2022: Focus on Key Therapeutic Sectors - Glucose, Immune Factors, Electrolytes/Potassium and Biomarker-enabled Diagnostics

·4 min read

DUBLIN, June 23, 2022 /PRNewswire/ -- The "Microneedle Measurable Chronic Disease Biomarkers" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo

Biomarkers are a key medical product development tool capable of facilitating development of medical products and spurring innovation. When used in the right context, biomarkers have the potential to help expedite patient access to safe and effective treatments by reducing the time and cost of clinical trials while maintaining patient protections. FDA encourages the integration of biomarkers in medical product development and approval, to facilitate the monitoring of FDA-regulated products, and their appropriate use in clinical practice.

Biomarkers promise to reduce stagnation and foster innovation in the development of new medical products. A biomarker can be used as the basis for creating a routine diagnostic test for clinical use, after it has been approved as an in-vitro diagnostic. A biomarker can also be used to develop a companion diagnostic test that enables better decision-making on the use of a therapy that is tailored to the patient.

Biomarkers are biochemical molecules that indicate how the human body may react to certain active pharmaceutical ingredients (APIs) or different types of environmental factors. A simple but well-known example of the role of biomarkers in patient health and well-being would be food allergies. By identifying biomarkers in human physiology and understanding their role in drug therapy, allergies and immune reactions, caregivers are better able to help patients avoid drug side effects and to determine when a particular drug will produce the desired therapeutic effect for a given patient.

The FDA has assembled a database titled Table of Pharmacogenomic Biomarkers in Drug Labeling. This information resource illustrates identified relationships between drugs and biomarkers. Knowing which patients exhibit certain types of biomarkers is therefore desirable. Researchers and investigators are interested in finding ways to identify, measure and quantify biomarkers in ways that are non-invasive, or at least minimally invasive to minimize any discomfort to the patient.

Microneedles are one of the ways being explored to sample, measure and quantify biomarkers for specific diseases. Using microneedles to collect biomarkers in the interstitial fluid (ISF) can be an inexpensive and rapid method for assessing the role of biomarkers in therapeutics and disease management.

This report covers these areas and describes the current state of technology.

What You Will Learn

  • What companies are active in the microneedle diagnostics segments, what distinguishes their technology, and what is their market presence?

  • What are the identified and verified chronic disease biomarkers, and what are their properties ?

  • What are the major factors that are influencing interest in chronic disease biomarkers?

  • What are the design factors, material selection issues, technologies, and market development issues for microneedles capable of capturing and identifying chronic disease biomarkers?

  • What are the important therapeutic markets for microneedle measurable chronic disease biomarkers? What is their market potential?

  • What are the significant economic, technology, and regulatory factors affecting the market for diagnostic microneedles?

Key Topics Covered:

Executive Summary

  • Microneedle Measurable Chronic Disease Biomarkers

  • Point-of-Care Diagnostics Market Dynamics

  • Biomarkers and their Potential in Clinical Medicine

  • Microneedles for Detecting and Measuring Biomarkers

Microneedle Product Categories

  • Solid Microneedles

  • Hollow Microneedles

  • Coated Microneedles

  • Dissolving Microneedles

  • Stretched Needles

  • Carbon Nanotubes

  • Ion Etching

  • C-MEMS

  • Specialty Microneedles

  • Phase Transition

  • Microprocessor-based Devices

  • Composite Microneedles

  • Light-responsive Microneedles

  • Flexible Arrays

  • Microneedle Arrays & Array Geometries

  • Array Architectures

  • Microneedles & Microfluidics

  • Wearable Microneedles

  • The Role of Interstitial Fluid

Microneedle Diagnostics - Design Factors

  • Analyte Capture

  • Sample Acquisition

  • Biofluid Absorption

  • Electrochemical Sensing Methods

  • Optical Sensing Methods

  • Chronic Disease Associated Biomarkers

  • Biomarker Detection

Microneedle Fabrication

  • Micromolding

  • Microforming

  • Micromachining

  • Structured Films

  • Emerging Fabrication Methods

  • 3D Printing

  • Electrospun Arrays

  • Two-Photon Polymerization (2PP)

  • Magnetization-induced Self-assembly

  • Additive Fabrication Methods

  • Stereolithography

  • Fused Deposition Modelling

  • Digital Light Processing

  • Selective Laser Sintering

  • Selective Laser Melting

  • Inkjet Printing

  • Surface Modification

Diagnostic Microneedle Device Analysis

  • Micro Transdermal Interface Platform (MicroTIPs)

  • Mindera Health

  • Scibase (Nevisense)

  • Seventh Sense Biosystems

  • Sysmex

  • Chronic Disease Biomarkers

Opportunities Extend Across Numerous Therapeutic Areas

  • Anesthesiology

  • Cardiology

  • Endocrinology

  • Gastroenterology

  • Gynecology

  • Hematology

  • Inborn Errors of Metabolism

  • Infectious Diseases

  • Neurology

  • Oncology

  • Rheumatology

Microneedle Biomarker Diagnostics

Key Therapeutic Sectors

  • Glucose

  • Immune Factors

  • Electrolytes/Potassium

  • Biomarker-enabled Diagnostics

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/xm4d8y

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/world-microneedle-measurable-chronic-disease-biomarkers-industry-2022--focus-on-key-therapeutic-sectors---glucose-immune-factors-electrolytespotassium-and-biomarker-enabled-diagnostics-301573878.html

SOURCE Research and Markets